Technology Holdings is pleased to announce the strategic sale of our client, Chicago-based Insight Product Development, to global drug delivery leader Nemera.
The Technology Holdings team was instrumental in helping us find a partner in Nemera that shares a common vision to provide exceptional capabilities to their clients, from innovation through industrialization. We appreciate Technology Holdings’ depth of experience in the healthcare sector and their understanding of our specialized design & development capabilities.
As a services company, it was important for the management team that we could trust our adviser to understand and clearly represent our motivations for a transaction. From our initial meeting to the day of closing, the Technology Holdings team served as that trusted adviser in our search for the perfect strategic fit.
IPD provides product development innovation, design strategy, advanced R&D and design for commercialization services to medical device, life sciences and connected health customers. Headquartered in France, Nemera provides design, development and manufacturing solutions for drug delivery devices to the pharmaceutical, biotechnology and generics industries. IPD’s presence in the Midwest perfectly complements Nemera’s Center of Excellence in Europe.
The two organizations bring together the strengths of IPD’s front-end innovation, design research, human factors and design engineering with Nemera’s expertise in late-stage development capabilities, as well as clinical and commercial manufacturing capabilities. IPD’s user-centered design capabilities help clients discover, innovate and develop new products and solutions, as evidence by over 250 design & utility patents that the company has developed for clients such as Boston Scientific, Becton Dickinson and Shire Pharmaceuticals. IPD designed products have received multiple Red Dot, IDEA and other award-winning design & innovation recognition over the years.
The transaction is a further testament to Technology Holdings’ expertise in the design & innovation space, having most recently advised on the Continuum-EPAM and Syncroness-ALTEN transactions.